Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Therapeutic Targeting of TIM-4-L with Engineered T Cells for Acute Myeloid Leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 09, 2023
Chimeric TIM-4 receptor-modified T cells targeting phosphatidylserine mediates both cytotoxic anti-tumor responses and phagocytic uptake of tumor-associated antigen for T cell cross-presentation.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 08, 2023
Novel engineered chimeric engulfment receptors trigger T cell effector functions against SIV-infected CD4+ T cells.
Journal: Molecular therapy. Methods & clinical development
Published: June 21, 2022
Upregulation of CD47 Is a Host Checkpoint Response to Pathogen Recognition.
Journal: mBio
Published: June 25, 2020
Complex mammalian-like haematopoietic system found in a colonial chordate.
Journal: Nature
Published: December 01, 2017
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.
Journal: Nature
Published: March 29, 2017
Developmental cell death programs license cytotoxic cells to eliminate histocompatible partners.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 25, 2016
Dynamic Patterns of Clonal Evolution in Tumor Vasculature Underlie Alterations in Lymphocyte-Endothelial Recognition to Foster Tumor Immune Escape.
Journal: Cancer research
Published: May 04, 2015
Identification of a colonial chordate histocompatibility gene.
Journal: Science (New York, N.Y.)
Published: July 27, 2013
The genome sequence of the colonial chordate, Botryllus schlosseri.
Journal: eLife
Published: January 22, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026